On September 8, 2020 Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases, reported that Ardelyx management will participate in three upcoming investor conferences in September including (Press release, Ardelyx, SEP 8, 2020, View Source [SID1234564785]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 15th Annual BioPharma Virtual Conference on Wednesday, September 9th
22nd Annual H.C. Wainwright Global Investment Conference on Monday, September 14th with a presentation at 5:00 p.m. E.T.
Cantor Fitzgerald Global Healthcare Conference 2020 on Thursday, September 17th with a presentation at 12:40 p.m. E.T.
Both the H.C. Wainwright and Cantor Fitzgerald conference presentations will be available via webcast. To access the live webcasts of Ardelyx’s presentations, please visit the Events & Presentations page within the Investor section of the Ardelyx website at ir.ardelyx.com. A replay of the webcasts will be available on the Ardelyx website for 30 days following each conference.